loading
Precedente Chiudi:
$1.625
Aprire:
$1.63
Volume 24 ore:
38,390
Relative Volume:
0.11
Capitalizzazione di mercato:
$42.88M
Reddito:
$4.99M
Utile/perdita netta:
$-28.29M
Rapporto P/E:
-1.5388
EPS:
-1.0528
Flusso di cassa netto:
$-36.20M
1 W Prestazione:
+0.62%
1M Prestazione:
+1.25%
6M Prestazione:
+26.56%
1 anno Prestazione:
-14.74%
Intervallo 1D:
Value
$1.59
$1.63
Intervallo di 1 settimana:
Value
$1.58
$1.64
Portata 52W:
Value
$0.8502
$2.00

Lava Therapeutics Nv Stock (LVTX) Company Profile

Name
Nome
Lava Therapeutics Nv
Name
Telefono
31 6 3000 3035
Name
Indirizzo
YALELAAN 62, UTRECHT
Name
Dipendente
34
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-28
Name
Ultimi documenti SEC
Name
LVTX's Discussions on Twitter

Confronta LVTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LVTX
Lava Therapeutics Nv
1.63 42.75M 4.99M -28.29M -36.20M -1.0528
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.23 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
641.92 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.67 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
825.18 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.14 40.44B 447.02M -1.18B -868.57M -6.1812

Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-12 Downgrade Leerink Partners Outperform → Market Perform
2024-12-11 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2022-10-25 Iniziato H.C. Wainwright Buy
2021-04-19 Iniziato JP Morgan Overweight
2021-04-19 Iniziato Jefferies Buy
2021-04-19 Iniziato SVB Leerink Outperform
Mostra tutto

Lava Therapeutics Nv Borsa (LVTX) Ultime notizie

pulisher
09:47 AM

Will LAVA Therapeutics N.V. stock benefit from green energy trendsBond Market & Weekly Momentum Stock Picks - newser.com

09:47 AM
pulisher
08:38 AM

How LAVA Therapeutics N.V. stock valuations compare to rivalsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com

08:38 AM
pulisher
07:57 AM

Ranking LAVA Therapeutics N.V. among high performing stocks via toolsTrade Exit Report & Community Consensus Picks - newser.com

07:57 AM
pulisher
07:33 AM

Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsTrade Entry Report & Reliable Price Breakout Signals - newser.com

07:33 AM
pulisher
06:28 AM

Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com

06:28 AM
pulisher
05:09 AM

How to track smart money flows in LAVA Therapeutics N.V.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com

05:09 AM
pulisher
03:01 AM

Heatmap analysis for LAVA Therapeutics N.V. and competitorsJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com

03:01 AM
pulisher
03:01 AM

What indicators show strength in LAVA Therapeutics N.V.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com

03:01 AM
pulisher
02:05 AM

Is LAVA Therapeutics N.V. showing signs of accumulationJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com

02:05 AM
pulisher
01:23 AM

Reversal indicators forming on LAVA Therapeutics N.V. stock2025 Volatility Report & Weekly High Return Opportunities - newser.com

01:23 AM
pulisher
12:20 PM

Custom strategy builders for tracking LAVA Therapeutics N.V.Swing Trade & Daily Price Action Insights - newser.com

12:20 PM
pulisher
Nov 02, 2025

Can LAVA Therapeutics N.V. hit a new high this monthJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How analysts revise price targets for LAVA Therapeutics N.V. (4PKB) stock2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Market Growth Report & Stepwise Trade Signal Implementation - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Historical volatility pattern of LAVA Therapeutics N.V. visualizedWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Price momentum metrics for LAVA Therapeutics N.V. explained2025 Price Targets & Safe Entry Trade Signal Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 00:32:41 - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

What analysts say about LAVA Therapeutics NV 4PKB stockInsider Trading Activity & Low Cost Portfolio Tips - earlytimes.in

Oct 30, 2025
pulisher
Oct 29, 2025

What hedge fund activity signals for LAVA Therapeutics N.V. stockMarket Trend Report & AI Powered Buy/Sell Recommendations - fcp.pa.gov.br

Oct 29, 2025

Lava Therapeutics Nv Azioni (LVTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Lava Therapeutics Nv Azioni (LVTX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Cooperatieve Gilde Healthcare
10% Owner
Oct 16 '25
Sale
1.49
690,239
1,028,456
4,128,912
Cooperatieve Gilde Healthcare
10% Owner
Oct 14 '25
Sale
1.51
227,341
343,285
5,019,151
Cooperatieve Gilde Healthcare
10% Owner
Oct 13 '25
Sale
1.54
47,686
73,436
5,246,492
Cooperatieve Gilde Healthcare
10% Owner
Oct 10 '25
Sale
1.55
49,869
77,297
5,294,178
Cooperatieve Gilde Healthcare
10% Owner
Oct 09 '25
Sale
1.56
48,169
75,144
5,344,047
Cooperatieve Gilde Healthcare
10% Owner
Oct 08 '25
Sale
1.57
28,954
45,458
5,392,216
Versant Venture Capital VI, L.
10% Owner
Sep 19 '25
Sale
1.40
2,370,533
3,322,065
0
Versant Venture Capital VI, L.
10% Owner
Sep 19 '25
Sale
1.40
532,870
746,764
0
Versant Venture Capital VI, L.
10% Owner
Sep 17 '25
Sale
1.49
362,806
540,291
2,736,644
Versant Venture Capital VI, L.
10% Owner
Sep 18 '25
Sale
1.44
366,111
527,859
2,370,533
$37.52
price down icon 0.26%
$28.69
price up icon 0.17%
$101.01
price up icon 8.01%
$104.29
price up icon 0.38%
biotechnology ONC
$312.00
price up icon 0.54%
$185.85
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):